Methylphenidate use in males with Duchenne muscular dystrophy and a comorbid attention-deficit hyperactivity disorder.

[1]  S. Apkon,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan , 2018, The Lancet Neurology.

[2]  Carla M Bann,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management , 2018, The Lancet Neurology.

[3]  J. Vles,et al.  Brain-related comorbidities in boys and men with Duchenne Muscular Dystrophy: A descriptive study. , 2017, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[4]  M. Huss,et al.  Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity , 2017, Neuropsychiatric disease and treatment.

[5]  P. Hoekstra,et al.  An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder , 2017, Expert opinion on drug safety.

[6]  J. Buitelaar,et al.  Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine , 2017, CNS Drugs.

[7]  Pei-Shan Tsai,et al.  Diagnostic Accuracy of Rating Scales for Attention-Deficit/Hyperactivity Disorder: A Meta-analysis , 2016, Pediatrics.

[8]  A. Aldenkamp,et al.  Diagnostic overshadowing in a population of children with neurological disabilities: A cross sectional descriptive study on acquired ADHD. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[9]  A. Kornberg,et al.  Duchenne muscular dystrophy , 2015, Journal of paediatrics and child health.

[10]  V. Mautner,et al.  Pharmacotherapy of Attention Deficit in Neurofibromatosis Type 1: Effects on Cognition , 2014, Neuropediatrics.

[11]  L. Jakobson,et al.  Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: A review , 2013, Neuroscience & Biobehavioral Reviews.

[12]  Rachel Salmon,et al.  Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK) , 2013, European Journal of Human Genetics.

[13]  E. Bertini,et al.  Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. , 2012, The Journal of pediatrics.

[14]  M. Stein,et al.  ADHD Treatments, Sleep, and Sleep Problems: Complex Associations , 2012, Neurotherapeutics.

[15]  M. Willoughby,et al.  Parent and Teacher Ratings on the IOWA Conners Rating Scale , 2008 .

[16]  S. Waisbren,et al.  Cognitive and Psychological Profile of Males With Becker Muscular Dystrophy , 2008, Journal of child neurology.

[17]  J. Vles,et al.  Neuropsychiatric Disorders in Males With Duchenne Muscular Dystrophy: Frequency Rate of Attention-Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, and Obsessive—Compulsive Disorder , 2008, Journal of child neurology.

[18]  S. Cortese,et al.  Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future , 2007, Expert review of neurotherapeutics.

[19]  B. Horta,et al.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.

[20]  E. V. van Someren,et al.  Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  B. Herpertz-Dahlmann,et al.  Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[22]  C. V. Tjon Pian Gi,et al.  Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study , 2003, European Journal of Pediatrics.

[23]  J. Swanson,et al.  Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma , 2003, Psychopharmacology.

[24]  L. Kluwe,et al.  Treatment of ADHD in neurofibromatosis type 1 , 2002, Developmental medicine and child neurology.

[25]  J. McClellan,et al.  Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  C. Edelbrock,et al.  Manual for the Child: Behavior Checklist and Revised Child Behavior Profile , 1983 .

[27]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[28]  J. Morley,et al.  Brain function in Duchenne muscular dystrophy. , 2002, Brain : a journal of neurology.